181 related articles for article (PubMed ID: 35386327)
1. Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety.
Guo Y; Hu G; Xia Y; Li H; Yuan J; Zhang J; Chen Y; Guo H; Yang Y; Wang Y; Deng Z
Bioact Mater; 2022 Oct; 16():204-217. PubMed ID: 35386327
[TBL] [Abstract][Full Text] [Related]
2. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
Geng T; Leung E; Chamley LW; Wu Z
Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
[TBL] [Abstract][Full Text] [Related]
3. Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner.
Whitehead CA; Fang H; Su H; Morokoff AP; Kaye AH; Hanssen E; Nowell CJ; Drummond KJ; Greening DW; Vella LJ; Mantamadiotis T; Stylli SS
Cell Oncol (Dordr); 2023 Aug; 46(4):909-931. PubMed ID: 37014551
[TBL] [Abstract][Full Text] [Related]
4. LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.
Wu P; Guo Y; Xiao L; Yuan J; Tang C; Dong J; Qian Z
Cancer Immunol Immunother; 2023 Jul; 72(7):2179-2193. PubMed ID: 36853330
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
6. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
[TBL] [Abstract][Full Text] [Related]
7. miRNome and Proteome Profiling of Small Extracellular Vesicles Secreted by Human Glioblastoma Cell Lines and Primary Cancer Stem Cells.
Cifola I; Fratini F; Cardinali B; Palmieri V; Gatti G; Selmi T; Donzelli S; Sacconi A; Cesarini V; Marei HE; Papi M; Blandino G; Cenciarelli C; Falcone G; D'Agnano I
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009432
[TBL] [Abstract][Full Text] [Related]
8. A versatile engineered extracellular vesicle platform simultaneously targeting and eliminating senescent stromal cells and tumor cells to promote tumor regression.
Gong L; Chen Z; Feng K; Luo L; Zhang J; Yuan J; Ren Y; Wang Y; Zheng X; Li Q
J Nanobiotechnology; 2024 Mar; 22(1):105. PubMed ID: 38468249
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
10. A simple approach to re-engineering small extracellular vesicles to circumvent endosome entrapment.
Geng T; Tang M; Yee Paek S; Leung E; Chamley LW; Wu Z
Int J Pharm; 2022 Oct; 626():122153. PubMed ID: 36055444
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response.
Panzarini E; Tacconi S; Carata E; Mariano S; Tata AM; Dini L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171763
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced small extracellular vesicles as "carriages" promote tumor antigen release and trigger antitumor immunity.
Lin W; Xu Y; Chen X; Liu J; Weng Y; Zhuang Q; Lin F; Huang Z; Wu S; Ding J; Chen L; Qiu X; Zhang L; Wu J; Lin D; Qiu S
Theranostics; 2020; 10(11):4871-4884. PubMed ID: 32308755
[No Abstract] [Full Text] [Related]
14. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
15. Challenges in the Development of Drug Delivery Systems Based on Small Extracellular Vesicles for Therapy of Brain Diseases.
Loch-Neckel G; Matos AT; Vaz AR; Brites D
Front Pharmacol; 2022; 13():839790. PubMed ID: 35422699
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Extracellular Vesicles in Plasma from Glioblastoma Patients.
Osti D; Del Bene M; Rappa G; Santos M; Matafora V; Richichi C; Faletti S; Beznoussenko GV; Mironov A; Bachi A; Fornasari L; Bongetta D; Gaetani P; DiMeco F; Lorico A; Pelicci G
Clin Cancer Res; 2019 Jan; 25(1):266-276. PubMed ID: 30287549
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery.
Rayamajhi S; Nguyen TDT; Marasini R; Aryal S
Acta Biomater; 2019 Aug; 94():482-494. PubMed ID: 31129363
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
[TBL] [Abstract][Full Text] [Related]
19. Porcine Milk-Derived Small Extracellular Vesicles Promote Intestinal Immunoglobulin Production through pIgR.
Zeng B; Wang H; Luo J; Xie M; Zhao Z; Chen X; Wang D; Sun J; Xi Q; Chen T; Zhang Y
Animals (Basel); 2021 May; 11(6):. PubMed ID: 34073819
[TBL] [Abstract][Full Text] [Related]
20. Homotypic targeting and drug delivery in glioblastoma cells through cell membrane-coated boron nitride nanotubes.
De Pasquale D; Marino A; Tapeinos C; Pucci C; Rocchiccioli S; Michelucci E; Finamore F; McDonnell L; Scarpellini A; Lauciello S; Prato M; Larrañaga A; Drago F; Ciofani G
Mater Des; 2020 Jul; 192():108742. PubMed ID: 32394995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
